Diabetes and Vascular Disease

MTP28 - Diabetic Nephropathy: What Is the Evidence in 2026 for Management of Diabetic Nephropathy?

Monday, June 15, 2026

1:45 PM - 2:25 PM CT

Location: Room W375A

Meet the Professor Speaker(s)

Rodica Pop Busui, MD,PhD

Professor, Jordan Schnitzer Endowed Chair in Diabetes, Director Harold Schnitzer Diabetes Center, Division Head Endocrinology, Diabetes
OREGON HEALTH SCIENCES UNIVERSITY
Portland, OR, United States

Disclosure(s):

Rodica Pop Busui, MD,PhD: .NovoNordisk: Clinical Trial Investigator (), Consultant (); Averitas Pharma: Consultant (); Bayer Inc.: Clinical Trial Investigator (), Consultant (); Lexicon: Clinical Trial Investigator (), Consultant (); Roche Diagnostics: Consultant (); Vertex: Consultant ()

Learning Objectives:

Identify and stage diabetic kidney disease (DKD) using contemporary criteria.
Implement guideline-directed medical therapy (GDMT) to slow the progression of DKD.